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Alcohol exposure can affect brain development, leading to long-lasting behavioral
problems, including cognitive impairment, which together is defined as fetal alcohol
spectrum disorder (FASD). However, the fundamental mechanisms through which this
occurs are largely unknown. In this study, we report that the exposure of postnatal
day 7 (P7) mice to ethanol activates caspase-3 via cannabinoid receptor type-1
(CB1R) in neonatal mice and causes a reduction in methylated DNA binding protein
(MeCP2) levels. The developmental expression of MeCP2 in mice is closely correlated
with synaptogenesis and neuronal maturation. It was shown that ethanol treatment
of P7 mice enhanced Mecp2 mRNA levels but reduced protein levels. The genetic
deletion of CB1R prevented, and administration of a CB1R antagonist before ethanol
treatment of P7 mice inhibited caspase-3 activation. Additionally, it reversed the loss of
MeCP2 protein, cAMP response element binding protein (CREB) activation, and activity-
regulated cytoskeleton-associated protein (Arc) expression. The inhibition of caspase-3
activity prior to ethanol administration prevented ethanol-induced loss of MeCP2, CREB
activation, epigenetic regulation of Arc expression, long-term potentiation (LTP), spatial
memory deficits and activity-dependent impairment of several signaling molecules,
including MeCP2, in adult mice. Collectively, these results reveal that the ethanol-
induced CB1R-mediated activation of caspase-3 degrades the MeCP2 protein in the
P7 mouse brain and causes long-lasting neurobehavioral deficits in adult mice. This
CB1R-mediated instability of MeCP2 during active synaptic maturation may disrupt
synaptic circuit maturation and lead to neurobehavioral abnormalities, as observed in
this animal model of FASD.
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INTRODUCTION
Ethanol abuse during pregnancy is considered to be one of the
most common causes of non-genetic mental impairments in
the Western world (Mattson et al., 2011). It can cause a range
of developmental, cognitive, and behavioral problems, which
together is known as fetal alcohol spectrum disorder (FASD).
FASD is identified through pervasive neuropsychological
manifestations (Mattson and Riley, 1998; Mattson et al., 1998),
including the disturbance of hippocampus (HP) and neocortex
(NC) functions (Mattson et al., 1996b; Clark et al., 2000;
Bookstein et al., 2001), which cause learning and memory
abnormalities (Mattson et al., 1996a, 1999; Jacobson and
Jacobson, 1999; Clark et al., 2000; Kaemingk and Halverson,
2000; Willford et al., 2004; Rasmussen et al., 2006). Rodents
are the most frequently used animal model for FASD research,
and a major component of neurodevelopment in this species
takes place after birth (Tran et al., 2000; Cronise et al., 2001).
In rodents, the brain is especially susceptible to ethanol
exposure between postnatal days 4 and 10 (P4–10), which
is comparable to the third trimester of human pregnancy
(Bayer et al., 1993). Hence, for a third trimester equivalent
exposure, ethanol must be administered to neonate pups in
these species. A single day of binge-like ethanol treatment at
P7 elicits widespread caspase-3 activation (CC3, a marker of
neurodegeneration) in numerous regions of the brain, such
as the HP and NC (Ikonomidou et al., 2000; Saito et al.,
2010; Wilson et al., 2011; Sadrian et al., 2012; Subbanna
et al., 2013b); it causes persistent deficits in the olfactory
and hippocampal pathway (Wilson et al., 2011; Sadrian
et al., 2012) and impairs cognitive function in adults (Abel
et al., 1983; Bonthius and West, 1991; Bellinger et al.,
1999, 2002; Berman and Hannigan, 2000; Alati et al., 2006;
Brown et al., 2007; Brady et al., 2013; Subbanna et al., 2013a,
2015a; Subbanna and Basavarajappa, 2014; Basavarajappa,
2015).
In spite of extensive studies (Ikonomidou et al., 2000;
Olney et al., 2002b; Hellemans et al., 2010; Saito et al., 2010;
Wilson et al., 2011; Sadrian et al., 2012; Subbanna et al.,
2013a,b, 2014; Olney, 2014; Subbanna and Basavarajappa,
2014; Nagre et al., 2015), the molecular mechanisms
responsible for the developmental catastrophes induced by
ethanol are still poorly defined, making it hard to develop
effective treatment strategies for FASD. We have previously
shown that third trimester equivalent ethanol exposure in
P7 mice activated CB1R (Subbanna et al., 2013a, 2015b),
and induced global, as well as gene specific, epigenetic
changes (Nagre et al., 2015; Subbanna et al., 2015a) that
collectively caused neurobehavioral abnormalities in adult
animals that are comparable to the cognitive deficits found in
human FASD (Mattson et al., 2010, 2011; Weyrauch et al.,
2017). A growing array of new research has portrayed
many intriguing ways in which the endocannabinoid
system (for review, see Basavarajappa, 2007a; Pava and
Woodward, 2012), which includes endogenous ligands
(endocannabinoids, ECs), receptors and EC catabolizing
enzymes (Piomelli, 2003; Basavarajappa, 2007b), has a vital
function in controlling neurobehavioral outcome (Ohno-
Shosaku et al., 2001; Wilson and Nicoll, 2001; Bacci et al., 2004)
in the developing and adult brain (see Basavarajappa et al.,
2009, 2017; Basavarajappa, 2015; Henderson-Redmond et al.,
2016).
Methylated DNA makes essential contributions to
mammalian development and function (Attwood et al., 2002;
Bergman and Cedar, 2013; Basavarajappa and Subbanna,
2016; Subbanna et al., 2016) through its regulation of
gene expression (Bird, 2002). DNA methylation silences
gene expression partly through recruitment of methyl-CpG
binding proteins (MeCP2), which selectively associate with
methylated cytosine-phospho-guanine (CpG) dinucleotides.
Furthermore, MeCP2 silences transcription by recruiting
additional repressive factors that regulate histone acetylation
and methylation (Jones et al., 1998; Nan et al., 1998; Nielsen
et al., 2001), and operates as a mechanistic bridge between
DNA and histone methylation, consequently reinforcing
the repressive function of these two distinct epigenetic
events (Fuks et al., 2003). Thus, genetic ablation of the
MeCP2 gene leads to defects in synaptic development
and maturation, and a complete loss of MeCP2 function
leads to brain development disorders like Rett Syndrome
(RTT), which is a severe autism spectrum disorder (Amir
et al., 1999; Chen et al., 2001; Moretti et al., 2006). Several
studies have suggested that both DNA methylation and
DNA-associated histone modification, which are two of the
most commonly studied epigenetic modifications that are
important in integrating gene expression in various cells
(Reik, 2007; Suzuki and Bird, 2008; Ma et al., 2010), are
altered by developmental ethanol exposure. Studies show
that ethanol exposure during early brain growth leads to
genome-wide/gene-specific alterations in DNA-associated
histone protein posttranslational modifications (Kim and
Shukla, 2005; Park et al., 2005; Pal-Bhadra et al., 2007; Moonat
et al., 2013; Subbanna et al., 2013b) and alterations in DNA
methylation (Garro et al., 1991; Haycock and Ramsay, 2009;
Liu et al., 2009; Ouko et al., 2009; Downing et al., 2011;
Zhou et al., 2011), as well as impaired DNA methylation
enzymes (Mukhopadhyay et al., 2013; Nagre et al., 2015)
and altered long-lasting phenotypes (Subbanna et al., 2016)
that resemble those of fetal alcohol syndrome (Kaminen-
Ahola et al., 2010). Together, these critical findings suggest
that epigenetic responses to developmental ethanol exposure
have the capacity to act as efficient epigenetic modulators
and induce impairments in neuronal maturation, leading to
long-lasting synaptic dysfunction (Izumi et al., 2005; Noel
et al., 2011; Wilson et al., 2011; Subbanna et al., 2013a, 2015a;
Subbanna and Basavarajappa, 2014). In our recent study
(Nagre et al., 2015), ethanol-induced CB1R-mediated caspase-3
activation was shown to reduce DNA methyltransferase
(DNMT1 and DNMT3A) protein levels, leading to the loss
of DNA methylation. This present study was undertaken
to examine the influence of postnatal ethanol treatment on
CB1R-mediated caspase-3-facilitated MeCP2 loss and its
impact on neurodegeneration and several neurobehavioral
abnormalities.
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MATERIALS AND METHODS
Experimental Animals
CB1R knockout (KO), and wild-type (WT) male and female
littermates were obtained from a CB1R heterozygous breeding
colony (C57BL/6J background; Steiner et al., 1999) at Nathan
Kline Institute for Psychiatric Research (NKI). C57BL/6J mice or
CB1R KO and WT mice that are on the C57BL/6J background
were housed in groups in standard cages at 21–24◦C with
40%–60% humidity, a 12-h light/12-h dark cycle, and access
to food and water ad libitum. Animal care and handling
practices were approved by the Animal Use Subcommittee of the
NKI (NKI IACUC) and followed National Institutes of Health
guidelines. The CB1R KO and WT mice were genotyped using
polymerase chain reaction (PCR) analysis of genomic DNA taken
from the mouse tails as previously described by our laboratory
(Basavarajappa et al., 2003).
Experimental Ethanol Model
Animal models have been widely used to investigate the
relationship among ethanol levels, drinking patterns and brain
damage (Maier et al., 1999; Maier and West, 2001; Ethen
et al., 2009). Some of those studies have demonstrated a nearly
linear inverse relationship between ethanol dose and damage
to the developing brain (Maier et al., 1999; Maier and West,
2001; Ethen et al., 2009). Because synaptogenesis takes place
after birth in mice (Tran et al., 2000; Cronise et al., 2001),
we have administered ethanol to neonate pups to mimic third
trimester alcohol exposure in humans. In the present study,
we followed an ethanol administration paradigm that does not
cause lethality and was shown to cause substantial apoptotic
neurodegeneration in P7 mice (Olney et al., 2002a). In each
litter, half of P7 (based on the day of birth) male and female
pups were treated subcutaneously (s.c.) with saline and ethanol
(2.5 g/kg s.c. at 0 h and again at 2 h) as described previously
(Wilson et al., 2011; Sadrian et al., 2012; Subbanna et al.,
2013a,b). The pups and dams remained together until they
were sacrificed, and the pup brains were removed 4–24 h after
the first saline/ethanol treatment. To determine blood ethanol
levels (BELs), the pups were euthanized through decapitation,
and truncal blood was taken at 4 and 9 h following the first
ethanol injection. The pup serum ethanol concentrations were
then analyzed using an alcohol dehydrogenase-based method
(Lundquist, 1959).
Drug Treatment
In our previous studies, administration of a CB1R antagonist
(SR141716A; a gift from RBI, Natick, MA, USA) or use of CB1R
KO mice prevented P7 ethanol activated caspase-3 (Subbanna
et al., 2013a; Subbanna and Basavarajappa, 2014). In the current
study, we used SR141716A and CB1R KO mice to block
ethanol-induced caspase-3 activation in P7 mice. SR141716A
was dissolved in ethanol (10 µl) followed by Tween 80 (10 µl)
and the rest of the volume was adjusted with a sterilized
saline. The drug (SR) was administered (1 mg/kg) by s.c.
injection at a volume of 5 µl/g body weight 30 min before
ethanol treatment. The vehicle (ethanol (10 µl), followed by
Tween 80 (10 µl) and saline), was administered as a control.
The pups remained with the dams till were sacrificed, and
the pup brains were removed 8 h after the first saline/ethanol
treatment. Intoxication (sleeping time) as a result of P7 ethanol
exposure was not affected by SR administration (Subbanna
et al., 2013a,b). P7 mice that were treated with SR exhibited no
damage to any of the organs (Subbanna et al., 2013a,b). The
broad-spectrum caspase inhibitor, quinoline-Val-Asp (Ome)-
CH2-O-phenoxy (Q-VD-OPh; SM Biochemicals, Anaheim, CA,
USA; 1 mg/kg; Subbanna et al., 2013b) was dissolved in
sterile saline and administered by s.c. injection at a volume
of 5 µl/g body weight 30 min prior to ethanol treatment. In
some experiments, saline, ethanol, saline + Q-VD-OPh and
ethanol + Q-VD-OPh treated mice were weaned and allowed
to mature to adulthood. Three-month-old male and female
mice were used for behavior analysis. Male mice were used for
long-term potentiation (LTP) and activity-dependent signaling
experiments.
Protein Extraction, Electrophoresis and
Immunoblotting
Four to twenty-four hours after the first saline or ethanol
treatment, P7 mice were sacrificed by decapitation. The dissected
HP and NC were flash frozen and stored at −80◦C. Tissue
homogenates containing freshly added phosphatase inhibitors
and 1% protease inhibitor mixture (Roche, Indianapolis, IN,
USA) were subjected to cytosolic and nuclear fractionation.
Nuclear fraction was further processed using nuclear extraction
buffer (Grabowski, 2005) in accordance to the manufacturer’s
instructions (Thermo Fisher Scientific, Suwanee, GA, USA) as
described before (Basavarajappa et al., 2008, 2014; Basavarajappa
and Subbanna, 2014). The samples were stored at −80◦C.
Developmental brain nuclear fractions were prepared by
sacrificing P2 to P90 mice according to their date of birth.
The western blots were incubated with anti-mouse activity
regulated cytoskeleton-associated protein (Arc; monoclonal,
# sc17838, 1:1000; Santa Cruz Biotechnology, CA, USA),
anti-rabbit MeCP2 (monoclonal, # 3456, 1:1000), anti-rabbit
cleaved caspase-3 (CC3; Asp175; polyclonal, #9661, 1:1000),
anti-rabbit CREB (monoclonal, #9197, 1:1000) anti-rabbit
phospho-CREB (monoclonal, #9198, 1:1000) and anti-mouse
β-actin (monoclonal, #3700, 1:1000; Cell Signaling, Danvers,
MA, USA) antibodies for 3 h at room temperature or
overnight at 4◦C and processed (Basavarajappa et al., 2008).
Incubation of western blots with a secondary antibody (goat
anti-mouse peroxidase conjugate, #AP 124P, 1:5000, Millipore;
goat anti-rabbit, #AP132P, 1:5000, Millipore) alone produced no
bands.
Immunohistochemistry
The free-floating sections were prepared according to our
previously described protocols (Subbanna et al., 2013a,b). In
double-labeling studies, the free-floating brain sections obtained
8 h after the first saline or ethanol treatment were subjected
to dual immunofluorescence labeling as described previously
(Subbanna et al., 2013a,b). We used anti-mouse 5mC (#BY-
MECY-0100, 1:500, Anaspec Inc., Fremont, CA, USA) or
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anti-rabbit MeCP2 to label methylated cytosine or MeCP2,
respectively, in matured neurons (anti-rabbit NeuN, #24307,
1:200, Cell Signaling, Denvers, MA, USA or anti-mouse NeuN,
MAB377, 1:200, EMD Millipore, Billerica, MA, USA). Alexa
Fluor 488 or 568 conjugated secondary antibodies (Invitrogen,
NY, USA) were used in these studies. Anti-rabbit 5mC or
anti-rabbit MeCP2 and anti-mouse NeuN antibodies were
omitted to determine the specificity of secondary antibodies.
The Mander’s correlation coefficient was used to measure the
colocalization of 5-mC or MeCP2 with NeuN-positive neurons
(Emi et al., 2013; Subbanna et al., 2016) using LSM-880 with
Airyscan and Zen Imaging software. Colocalization was analyzed
by selecting CA1 and cortex brain regions.
DNA Methylation Assay and 5-mC Dot Blot
The pups were decapitated at 8 h (the ideal time for
maximum caspase-3 activation) after P7 ethanol administration,
and the HP and NC tissues were dissected, flash frozen
and stored at −80◦C. Qiagen DNA Extraction Kit (Qiagen
Sciences, Germantown, MD, USA) was used to isolate genomic
DNA from the HP and NC tissues. Epigentek (Farmingdale,
NY, USA) MethylFlash DNA Methylation Quantification
Kit (Colorimetric) was used to determine the global DNA
methylation levels (Nagre et al., 2015; Subbanna et al., 2016). The
5-mC levels were determined using the formula provided in the
kit and was normalized to the percentage in the saline control
(the graphs represent the DNA methylation levels multiplied by
an arbitrary factor to set the saline group to 100). For the dot blot
assay, DNA samples (200 ng, 100 ng and 50 ng) were dot-blotted
onto a 0.2 µm nitrocellulose membrane in a total volume of 1 µl
per sample. The membranes were processed as described before
by our laboratory (Basavarajappa et al., 2008; Subbanna et al.,
2016) and incubated with a primary rabbit anti-5-methylcytosine
antibody (1:500, # BY-MECY-0100, AnaSpec Inc., Fremont, CA,
USA). The dot blots were normalized to the percentage in the
saline-treated samples.
Quantitative Real-Time Polymerase Chain
Reaction (RT-qPCR)
Four to twenty-four hours after the first saline or ethanol
treatment, P7 mice were sacrificed by decapitation, and the
dissected HP and NC were flash frozen and stored at
−80◦C. The HP and NC tissues were used for a total RNA
preparation using an RNeasy Mini Kit (Qiagen, Valencia, CA,
USA) as described before (Subbanna et al., 2013b). RT-qPCR
analysis of Mecp2 was performed (Integrated thermocycler and
fluorescence detector ABI PRISM 7900HT Sequence Detector,
Applied Biosystems, Thermo Fisher Scientific, Grand Island,
NY, USA) using the predeveloped TaqManr Gene Expression
Assays and primer mixtures Mm00521967_m1 (Mecp2) and
4352932 (Gapdh; Applied Biosystems, Thermo Fisher Scientific,
Grand Island, NY, USA). The cDNA was amplified in
Stratagene Mx3000P QPCR systems (Agilent Technologies,
Santa Clara, CA, USA) by quantitative RT-PCR using SYBR
Green PCR Master Mix (Applied Biosystems, Warrington,
UK). The Arc primer (forward, 5′-GGTGAGCTGAAGCCACA
AAT-3′ and reverse, 5′-GCTGAGCTCTGCTCTTCTTCA-3′)
was selected from https://mouseprimerdepot.nci.nih.gov. The
gene expression profile for Mecp2 and Arc were normalized
to the corresponding Gapdh and Hprt levels respectively for
each sample. Experiments with each set of samples were
repeated as three separate runs with triplicate reactions. The
data were calculated using SDS2.4 software (Applied Biosystems,
Thermo Fisher Scientific, Grand Island, NY, USA). The relative
expression level ofMecp2 or Arc (fold level) were analyzed using
the 2−∆∆Ct method (Livak and Schmittgen, 2001).
Spatial Memory (SM) Using the Y-maze
A separate cohort of male and female mice (3 months old;
n = 8/group) treated with saline, ethanol, saline + Q-VD-OPh
or ethanol + Q-VD-OPh at P7 were subjected to an Spatial
Memory (SM) task (Dellu et al., 1992), which was performed
(Sarnyai et al., 2000) using a symmetrical Y-maze precisely as
outlined previously (Basavarajappa et al., 2014; Basavarajappa
and Subbanna, 2014). Briefly, the entry to one arm (the novel
arm) of Y-maze was blocked using a sheet of opaque paper during
the training trials (10 min). After a 24 h intertrial interval, the
mice were allowed to explore all three arms (3 min, preference
trial). The number of arm entries and the time spent in each
arm were noted manually from video recordings by an observer
blind to the treatment of the mice. The discrimination ratio for
arm entries and dwell time was calculated using the following
formula [preference for the novel arm over the familiar other arm
(Novel/Novel + Other)].
Spontaneous Alternation on Y Maze
Individual mouse was placed in the center of the Y maze and
was allowed to explore freely through the maze during an
8 min session. The sequence, time spent in each arm and total
number of arms entered was recorded. Complete arm entry
was considered when the hind paws of the mouse had been
totally placed in the arm. Percentage alternation is calculated as
described before by our laboratory (Basavarajappa et al., 2014;
Basavarajappa and Subbanna, 2014).
Social Recognition Memory (SRM)
A separate cohort of male mice (3 months old; n = 8/group)
treated with saline, ethanol, saline + Q-VD-OPh or ethanol
+ Q-VD-OPh at P7 were subjected to an Social Recognition
Memory (SRM) task (Thor et al., 1982; Kogan et al., 2000)
that was performed exactly as described earlier (Subbanna and
Basavarajappa, 2014). The experimental cages used for this task
were the same as those in which the mice were housed (plastic,
27 cm long × 16 cm wide × 12 cm high). In brief, animals
were habituated to the new experimental cage by placing an
individual adult mouse (male or female) in the cage for 15 min.
Immediately after the 15 min of habituation, a juvenile mouse
(same sex as the adult; 3–4 weeks old) was introduced into
the experimental cage with the adult for an initial contact
trial of 2 min. The animals were placed back in their original
home cages during the intertrial interval (24 h periods). After
24 h (intertrial delay), the aforementioned juvenile mouse was
placed back into the adult’s cage in order to conduct a 2-min
test trial. The duration of the social investigation (with a
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hand-held stopwatch) was recorded by a trained observer. The
social investigative behaviors, such as direct interaction with
the juvenile while checking any part of the body (including
grooming, licking and pawing); sniffing of the mouth, ears, tail,
anogenital region; and close following (within 1 cm) of the
juvenile (Thor et al., 1982; Kogan et al., 2000), were recorded.
The adult mouse that failed to investigate the young mouse
for a minimum of 24 s during the initial trial (i.e., 20% of
the test time) was re-examined once with another juvenile. The
sessions with initial investigation times less than 24 s or any
aggressive encounter between the animals were eliminated and
the social investigation (%) was calculated as described previously
(Basavarajappa et al., 2014; Basavarajappa and Subbanna, 2014;
Subbanna and Basavarajappa, 2014; Subbanna et al., 2016).
LTP
Male mice (3 months old; n = 5/group) treated with saline,
ethanol, saline + Q-VD-OPh or ethanol + Q-VD-OPh at P7 were
sacrificed by cervical dislocation followed by decapitation. HP
slices (400 µm) were prepared as described before (Subbanna
et al., 2013a). Electrophysiological recording was performed
using a standard procedure as described earlier (Subbanna et al.,
2013a; Basavarajappa et al., 2014; Basavarajappa and Subbanna,
2014; Subbanna and Basavarajappa, 2014). Briefly, following
cutting, slices were placed in a recording chamber (29◦C)
and perfused with artificial cerebrospinal fluid (ACSF in mM:
124.0 NaCl, 4.4 KCl, 1.0 Na2HPO4, 25.0 NaHCO3, 2.0 MgSO4,
2.0 CaCl2, 10.0 glucose, osmolarity 290–300) continuously
bubbled with 95% O2 and 5% CO2. The stimulating and the
recording electrodes were placed in the CA1 stratum radiatum
and CA1 field-excitatory-post-synaptic potentials (fEPSPs) were
recorded. The stimulus voltages were plotted against the fEPSP
slopes to determine basal synaptic transmission (BST). A
baseline was recorded up to 10 min at an intensity that evokes
approximately 35% of the maximum evoked response. LTP
(four pulses at 100 Hz, with the bursts repeated at 5 Hz, and
each tetanus including 3 × 10-burst trains separated by 15 s)
was induced by tetanic stimulation of the Schaeffer collateral
pathway. Responses were recorded for 2 h after, and measured
as the fEPSP slope expressed as a percentage of the baseline.
Activity-Dependent Regulation of Signaling
Events and Arc Expression
A separate cohort of male mice (3 months old; n = 8/group)
treated with saline, ethanol, saline + Q-VD-OPh or ethanol
+ Q-VD-OPh at P7 were subjected to an SM task (Dellu
et al., 1992), which was performed (Sarnyai et al., 2000)
using the symmetrical Y-maze (SM) exactly as outlined before
(Basavarajappa et al., 2014; Basavarajappa and Subbanna, 2014).
After a 24 h intertrial interval, when the mice completed
exploring all three arms (3 min, preference trial; test trial), the
mice were sacrificed immediately. Hippocampi were collected
and processed for analysis of several signaling molecule levels
using western blotting, as described previously. The western
blots were incubated with anti-rabbit MeCP2 (monoclonal, #
3456, 1:1000, Cell Signaling Technology, Danvers, MA, USA),
anti-mouse phospho-MeCP2 (# PIPA535396, 1:1000, Fischer
Scientific, Boston, MA, USA, anti-mouse CamKIV (monoclonal,
# 610275, 1:1000, BDBiosciences, San Jose, CA, USA), anti-rabbit
phospho-CaMKIV (Polyclonal # sc28443, 1:1000), anti-mouse
Arc (monoclonal, # sc17838, 1:1000; Santa Cruz Biotechnology,
CA, USA), anti-rabbit CREB (monoclonal, #9197, 1:1000),
anti-rabbit phospho-CREB (monoclonal, #9198, 1:1000), and
anti-mouse β-actin (monoclonal, #3700, 1:1000; Cell Signaling
Technology, Denvers, MA, USA) antibodies for 3 h at room
temperature, or overnight at 4◦C, and processed as previously
described by our laboratory (Basavarajappa et al., 2008). Western
blots incubated with a secondary antibody (goat anti-mouse
peroxidase conjugate, #AP 124P, 1:5000, Millipore; goat anti-
rabbit, #AP132P, 1:5000, Millipore) alone produced no bands.
Chromatin Immunoprecipitation (ChIP)
Assay
ChIP was performed as described previously (Subbanna et al.,
2014, 2015a). Briefly, adult mouse HP tissue (25 mg) was fixed
with 1% formaldehyde, homogenized and subjected to DNA
shearing; the amount of sample was normalized to contain
equivalent protein amounts. An aliquot of precleared chromatin
was used as the input. Chromatin was immunoprecipitated with
antibody recognizing normal rabbit IgG as a negative control
and with anti-H3K9me2 and anti-H3K14ace antibodies. The
quantification of immunoprecipitated DNA and normalization
vs. total DNA (input) were performed using real-time qPCR
with mouse primers (forward, 5′-AGTGCTCTGGCGAGTAG
TCC-3′ and reverse, 5′-TCGGGACAGGCTAAGAACTC-3′)
designed to amplify short regions of the Arc gene promoter.
Relative quantification of H3K9me2- and H3K14ace-associated
genes in saline and treatment groups was performed using the
∆∆Ct method (Schmittgen and Livak, 2008).
Statistical Analysis
The experiments were performed and assessed with an equal
number of P7 or P90 mice/treatment. One-way analysis
of variance (ANOVA) or two-way ANOVA followed by
Bonferroni’s post hoc test was used for a statistical comparison
of the data and performed using Prism software (GraphPad, San
Diego, CA, USA). The level of significance was set at p < 0.05,
and all results are reported as the mean ± SEM of at least three
independent experiments.
RESULTS
P7 Ethanol Treatment Activates Caspase-3
and Reduces DNA Methylation and
MeCP2 Protein Levels in the Neonatal
Brain
Ethanol (2.5 g/kg, s.c. at 0 h and again at 2 h) treatment
of P7 mice resulted in BELs of 0.38 ± 0.3 g/dl at 4 h that
steadily reached 0.22 ± 0.05 g/dl at 9 h after the first ethanol
administration. We performed IHC using CC3 antibody and
found CC3 staining throughout the forebrain. Western blot
analysis was also performed in saline, 8 h and 24 h ethanol
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groups and the results suggested that a significantly higher
CC3 protein levels in both the HP and NC tissues (data not
shown) as observed in our previous studies (Subbanna et al.,
2013a,b; Nagre et al., 2015). Thus, binge-like ethanol treatment
of P7 mice recapitulated neurodegeneration conditions as
observed previously (Ikonomidou et al., 2000; Subbanna et al.,
2013a).
Because degenerating neurons in ethanol-exposed P7 mice
undergo nuclear changes that lead to caspase-3-mediated loss
of DNA methyltransferases (DNMT1 and DNMT3A), and thus
reduced DNA methylation (Nagre et al., 2015), we examined
DNA methylation status and MeCP2 levels in ethanol-treated
P7 mice. Consistent with our previous observation (Nagre et al.,
2015), we found that P7 ethanol treatment significantly reduced
DNA methylation (HP, F(1,36) = 92, p < 0.01; NC, F(1,36) = 80,
p < 0.01; one-way ANOVA; Figure 1A). We found a significant
drop in the amount of 5-mC in genomic DNA from the HP
(F(1,46) = 55, p < 0.01) and NC (F(1,46) = 60, p < 0.01; one-way
ANOVA with Bonferroni’s post hoc tests) of ethanol-treated
P7 mice compared with the saline-treated mice (Figure 1B),
as determined by dot blot. The dot blots were normalized to
the percentage of 5-mC in the saline-treated mouse samples
(the graphs represent the 5-mC levels multiplied by an arbitrary
factor to set the saline-treated sample levels to 100). IHC of
5-mC and NeuN, followed by Mander’s coefficient analysis,
suggests that ethanol treatment significantly reduced the number
of 5-mC-positive NeuN neurons compared with saline treatment
in both CA1 (F(3,28) = 29, p< 0.01) and retrosplenial cortex (RSC;
F(3,28) = 32, p < 0.01; one-way ANOVA with Bonferroni’s post
hoc tests) regions (Figure 1C).
To understand the developmental pattern of
MeCP2 expression in the mouse brain, we determined the
MeCP2 protein levels at various developmental stages. NC
nuclear protein extracts from P2 to P90 developmental stages
were subjected to western blotting. MeCP2 protein levels
were significantly (F(8,45) = 80, p < 0.05) elevated through
synaptogenesis and up to the adulthood (P90; Figure 2A) levels
compared with the P2 developmental stage. Next, we tested the
effects of ethanol treatment of P7 mice on MeCP2 expression
in the HP and NC. We determined the mRNA levels, and the
results revealed thatMecp2mRNA levels increased at the 8 h and
24 h time points in the HP (F(3,28) = 13, p < 0.01) and were
enhanced at 24 h in the NC (F(3,28) = 80, p < 0.01; Figure 2B)
after administration of the first ethanol dose. The levels of the
endogenous mRNA control Gapdh were not significantly altered
at any time point (data not shown), and Gapdh mRNA values
were used to normalizeMecp2 gene expression data. In our next
experiment, we used western blotting to measure protein levels.
Ethanol treatment decreased MeCP2 protein levels in the HP
(F(3,28) = 7, p < 0.01; 4–24 h) and NC (F(3,28) = 19, p < 0.01) at
the 8–24 h (after the first ethanol injection) time points when
compared with the saline control (0 h; Figure 2C). IHC of
MeCP2 and NeuN followed by Mander’s coefficient analysis
indicated that ethanol treatment significantly (p< 0.01) reduced
the number of MeCP2-positive NeuN neurons compared with
saline treatment in both CA1 (F(3,28) = 23, p < 0.01) and
RSC (F(3,28) = 27, p < 0.01) regions (one-way ANOVA with
Bonferroni’s post hoc tests; Figure 2D). These results suggest that
the net loss of MeCP2 proteins seen in ethanol-exposed mice
may be due to proteolytic degradation.
Pharmacological Blockade or Genetic
Deletion of CB1R Prevents the
Ethanol-Induced Reduction in
MeCP2 Protein Levels
To further evaluate whether the loss of MeCP2 proteins is due to
ethanol-induced caspase-3 activation, we used a specific CB1R
antagonist (SR141716A, SR), CB1R KO mice. In our previous
studies (Subbanna et al., 2013a, 2015a), both SR and CB1R
KO hinders ethanol-induced activation of caspase-3 without
significantly influencing ethanol metabolism. In our previous
studies (Subbanna et al., 2013a), SR dose-dependently inhibited
the ethanol-induced activation of caspase-3 (CC3 levels), with
maximum inhibition at 1 mg/kg (Subbanna et al., 2013a, 2015a).
Thus, we used SR at 1 mg/kg in our current studies. Our results
suggested that SR pre-administration completely rescued the
ethanol-induced decrease in MeCP2 protein levels in the HP
and NC (p > 0.01; Figure 3A) of P7 mice. Two-way ANOVA
with Bonferroni’s post hoc analysis suggested that there were
significant effects of ethanol (vs. saline; HP: F(1,20) = 23, p< 0.01;
NC: F(1,20) = 18, p < 0.01) and a significant interaction between
ethanol and SR (HP: F(1,20) = 13, p < 0.01; NC: F(1,20) = 18,
p < 0.01). Treatment with SR or a vehicle alone had no
significant effects on MeCP2 protein levels in the absence of,
or following ethanol treatment (p > 0.05). One-way ANOVA
with Bonferroni’s post hoc analysis for MeCP2 protein levels
in saline- and ethanol-treated P7 CB1R KO and WT mice
demonstrated that, consistent with the SR pretreatment results,
CB1R KO provided protection against the P7 ethanol-induced
decrease in MeCP2 protein levels in the HP (F(1,20) = 16,
p < 0.01) and NC (F(1,20) = 20, p < 0.01; Figure 3B). Together,
these results suggest that a blockade or genetic ablation of
CB1Rs prevents the ethanol-induced loss of MeCP2 protein
in the HP and NC of the P7 mouse brain through caspase-3
activation.
Inhibition of Caspase-3 Activity before
Ethanol Treatment Prevents the
Ethanol-Induced Reduction in
MeCP2 Protein Levels
The loss of MeCP2 protein provoked us to further examine
the possibility of caspase-3-mediated degradation; therefore,
we used Q-VD-OPh in our experiments. Q-VD-OPh prevents
caspase-3 cleavage into its 17 kDa active fragment in vivo in
P7 rats (Renolleau et al., 2007) and mice (Subbanna et al.,
2013b). This compound is significantly more effective and less
toxic than the widely used caspase-3 inhibitors in preventing
apoptosis (for references see; Renolleau et al., 2007; Subbanna
et al., 2013b). In our previous studies (Subbanna et al., 2013b;
Nagre et al., 2015), we found that Q-VD-OPh rescues the
ethanol-induced formation of CC3 and prevents dimethylated
histone H3 lysine 9 (H3K9me2), total histone H3, DNMT1 and
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FIGURE 1 | Treatment of postnatal day 7 (P7) mice with ethanol reduces DNA methylation in the brain. (A) Global DNA methylation was reduced by ethanol
treatment. Global DNA methylation quantification in DNA from the hippocampus (HP) and neocortex (NC) obtained 8 h after the first saline or ethanol injection. For
the 0 h ethanol group, saline was injected. (∗p < 0.05, n = 10 pups/group). (B) Global 5-mC-specific dot-blot intensities of genomic DNA prepared from the HP and
NC (200 ng, 100 ng and 50 ng of genomic DNA) of P7 mice after treatment with saline or ethanol (8 h). The 5-mC-specific dot-blot intensities (%) compared with the
saline controls (∗p < 0.01 vs. Saline, n = 8 pups/group). (C) Free-floating coronal brain sections (HP and RSC) from both the groups (saline and 8 h ethanol) were
subjected to immunohistochemistry with anti-mouse 5mC and anti-rabbit NeuN antibodies to label 5-mC-positive NeuN in neurons. Mander’s coefficient analysis
was used to evaluate 5-mC-positive NeuN neurons in the CA1 and RSC brain regions. (∗p < 0.01 vs. Saline, n = 6 pups/group). Scale bars = 10 µm. Error bars,
SEM (one-way analysis of variance (ANOVA) with Bonferroni’s post hoc test).
DNMT3A protein degradation in the HP and NC. Q-VD-
OPh (1 mg/kg, s.c.) administration prior to ethanol exposure
of P7 mice did not affect the BELs (0.36 ± 0.2 g/dl at
4 h, steadily reduced to 0.24 ± 0.06 g/dl at 9 h after the
first ethanol exposure), suggesting that Q-VD-OPh does not
significantly change ethanol metabolism. We found that Q-VD-
OPh rescued the ethanol-induced loss of MeCP2 protein in the
HP (F(1,20) = 18, p < 0.01) and NC (F(1,20) = 19, p < 0.01;
Figure 3C). The Q-VD-OPh treatment had no significant
effect in the saline group (p > 0.05). Taken together, these
results suggest that the ethanol-induced loss of MeCP2 occurs
because of MeCP2 protein degradation induced by activated
caspase-3.
Pre-Treatment of P7 Mice with Q-VD-OPh
Rescues the Impaired pCREB and Arc
Protein Expression Observed in
Ethanol-Exposed P7 and Adult Mice
In order to examine the involvement of intracellular signaling
events in the long-lasting effects of ethanol on neurodevelopment
even further, we ascertained the levels of pCREB (activated),
CREB (total) and Arc proteins at 8 h post ethanol treatment.
Two-way ANOVA with Bonferroni’s post hoc analysis suggested
significant effects of ethanol (vs. saline; HP: F(3,33) = 43, p< 0.01;
NC: F(3,33) = 38, p < 0.01) and a significant interaction between
ethanol and Q-VD-OPh (HP: pCREB, F(3,33) = 23, p< 0.01; Arc,
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FIGURE 2 | MeCP2 protein expression pattern during mouse brain development; ethanol treatment of P7 mice enhances Mecp2 mRNA but impairs the protein
levels in the HP and NC regions. (A) MeCP2 protein expression pattern during mouse brain development. The MeCP2 expression pattern in neocortical nuclear
protein extract obtained from P2 to P90 mouse brains were subjected to western blotting. Equal protein loading was confirmed after Ponceau S staining, and β-actin
was used as the protein loading control. (∗p < 0.01 vs P2 groups; n = 12 pups/group). (B) RT-qPCR analysis of Mecp2 mRNA in HP and NC extracts obtained
4–24 h after the first saline or ethanol injection (n = 12 pups/group). Gapdh mRNA was used as the internal control for normalization of Mecp2 mRNA levels.
(C) Western blot analysis of MeCP2 proteins in the P7 HP and NC nuclear protein extracts (4–24 h after the first saline or ethanol treatment). β-actin was used as the
protein loading control. In the 0 h ethanol group, saline was injected [∗p < 0.01 vs. saline (0 h) group]. (n = 12 pups/group). (D) The coronal brain sections (HP,
hippocampus, and RSC, retrosplenial cortex; saline and 8 h ethanol) were used for immunohistochemistry with anti-mouse MeCP2 and anti-rabbit NeuN antibodies
to label MeCP2-positive NeuN in neurons. Mander’s coefficient analysis was used to evaluate MeCP2-positive NeuN neurons in the CA1 and RSC brain regions.
Error bars, SEM (∗p < 0.01 vs. Saline, n = 6 pups/group). Scale bars = 10 µm. Error bars, SEM (one-way ANOVA with Bonferroni’s post hoc test).
F(3,33) = 33, p< 0.01 and NC: pCREB, F(3,33) = 28, p< 0.01; Arc,
F(3,33) = 38, p< 0.01) in P7 mice. Q-VD-OPh or saline alone had
no significant effects on pCREB and Arc protein levels (p> 0.05)
in P7 mice (Figure 4A). To further evaluate whether pCREB and
Arc protein expression lasts into adulthood and could be rescued
by pre-administration of Q-VD-OPh at P7, we determined
pCREB and Arc protein expressions in HP and NC tissues
derived from adult mice. Two-way ANOVA with Bonferroni’s
post hoc analysis indicated that the ethanol effects on pCREB and
Arc are long-lasting and are significantly reduced in P7 ethanol-
treated adult mice (vs. saline) (HP: F(3,33) = 43, p < 0.01; NC:
F(3,33) = 41, p < 0.01) and that a significant interaction between
ethanol and Q-VD-OPh occurred (HP: pCREB, F(3,33) = 20,
p< 0.01; Arc, F(3,33) = 33, p< 0.01 and NC: pCREB, F(3,33) = 23,
p < 0.01; Arc, F(3,33) = 28, p < 0.01). P7 Q-VD-OPh or saline
treatment had no significant effects on pCREB and Arc protein
levels (p> 0.05) in adult mice (Figure 4B).
Ethanol-Induced Reduction in Arc
Expression in Adult Mice Is Regulated by
an Epigenetic Mechanism and Rescued by
Pre-administration of Q-VD-OPh in
P7 Mice
Next, we determined Arc mRNA levels in the adult HP.
Consistent with the protein expression results (Figure 4B),
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FIGURE 3 | CB1R antagonist (SR141716A) or CB1R knockout (KO) mice or
Q-VD-OPh protect against ethanol-mediated loss of MeCP2 proteins.
(A) P7 mice were pretreated with SR (1 mg/kg) 30 min before saline or ethanol
treatment. MeCP2 proteins from hippocampal (HP) and neocortical (NC)
nuclear extracts from the four treatment groups (S + V, E + V, S + SR and E +
SR) groups (n = 12 pups/group) were subjected to western blotting. S, saline;
E, ethanol. β-actin was used as the protein loading control. (∗p < 0.01 vs.
(Continued)
FIGURE 3 | Continued
S + V; #p < 0.01 vs. E + V). (B) P7 CB1R wild-type (WT) and CB1R KO mice
were treated with saline or ethanol. From nuclear extracts of HP and NC,
western blot analysis of MeCP2 protein was performed for all the four
treatment groups (S + CB1R WT, E + CB1R WT, S + CB1R KO + and E +
CB1R KO) groups (n = 12 pups/group). S, saline; E, ethanol. (∗p < 0.01 vs. S
+ CB1RWT; #p < 0.01 vs. E + CB1RWT). (C) P7 mice pre-treated for 30 min
with Q-VD-OPh (1 mg/kg) or vehicle were exposed to ethanol for 8 h, and
MeCP2 protein levels were examined in nuclear extracts of the HP and NC
from saline (S), ethanol (E), S + Q-VD-OPh, or E + Q-VD-OPh groups
(n = 12 pups/group) via western blot analysis. β-actin was used as the protein
loading control (∗p < 0.01 vs. S; #p < 0.01 vs. E. Error bars, SEM (two-way
ANOVA with Bonferroni’s post hoc test).
ethanol exposure at P7 significantly (F(3,33) = 44, p < 0.01;
two-way ANOVA with Bonferroni’s post hoc) reduced
Arc mRNA levels in the adult HP (Figure 4C), and
pre-administration of Q-VD-OPh at P7 rescued it, suggesting
that long-lasting Arc expression deficits are transcriptionally
regulated. It is well established that MeCP2 silences gene
transcription by recruiting the histone deacetylase (HDAC,
which removes acetyl groups from histones; Nan et al., 1997,
1998) or G9a (adds methyl groups to histones; Fuks et al.,
2003; Coward et al., 2017) repressive molecular machineries.
Additionally, reduced pCREB levels can impair recruitment
of the CREB binding protein, CBP (intrinsic histone acetyl
transferase activity, HAT adds acetyl groups to histones) to gene
promoters (Lonze and Ginty, 2002; Lubin et al., 2008). Together
these events can modulate H3K9me2 and H3K14ace, typical
epigenetic marks linked to repressed and active chromatin
(Basavarajappa and Subbanna, 2016), respectively, and alter Arc
expression. Thus, we analyzed these marks at the Arc promoter
by ChIP assay. Two-way ANOVA with Bonferroni’s post hoc
analysis suggested that P7 ethanol treatment significantly
increased H3K9me2 levels and decreased H3K14ace at the
Arc promoter region in the adult HP (vs. saline; F(3,33) = 56,
p < 0.01), and that there was a significant interaction between
ethanol and Q-VD-OPh (F(3,33) = 22, p < 0.01). P7 Q-VD-OPh,
or saline treatment, had no significant effects on H3K9me2 levels
or H3K14ace at the Arc promoter region (p> 0.05) in adult mice
(Figure 4D).
Pre-administration of Q-VD-OPh before
Ethanol Exposure Rescues
Ethanol-Induced Memory Loss in Adult
Mice
To examine whether inhibition of caspase-3 activation in P7mice
prevents the persistent ethanol-induced behavioral deficits
observed in our previous behavioral analysis (Subbanna et al.,
2013a; Nagre et al., 2015), we tested spatial recognition memory
using a Y-maze. Two-way ANOVA analysis suggested that
saline- or S + Q-VD-OPh-treated male (arm entry: F(3,33) = 29,
p < 0.01) and female (arm entry: F(3,33) = 32, p < 0.01) mice
entered (Figure 5A) arms more frequently and spent more
time (Figure 5B) in (dwell time: male, F(3,33) = 8, p < 0.01,
and female, F(3,33) = 10, p < 0.01) the novel, previously
unvisited arm of the maze. In contrast, P7 ethanol-treated
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male and female mice exhibited a lower preference toward
the novel arm (p < 0.01) and spent less time (dwell time;
p < 0.01) in the novel arm compared with the saline-treated
mice after 24 h of retention. Pre-administration of Q-VD-OPh
significantly rescued the ethanol-induced impairments (E + Q-
VD-OPh), with a preference toward exploration of the novel
arm (p < 0.01) and increased time spent (p < 0.01) in the
novel arm. These findings suggest that inhibition of caspase-3
before P7 ethanol treatment ameliorates the spatial recognition
memory defect in adult male and female mice. Due to the lack
of gender effects, we used only male mice in our remaining adult
studies.
In our second behavioral test to examine whether Q-VD-
OPh rescues ethanol-induced memory impairments, we tested
a spontaneous alternation in the Y maze (Lalonde, 2002) in
male adult mice. P7 S, E, S + Q-VD-OPh and E + Q-
VD-OPh treatment had no significant effect on the adult
exploratory activities, as assessed by the number of arm entries
(Figure 5C) and time spent (Figure 5D) in each arm during
the Y-maze test. Two-way ANOVA with Bonferroni’s post hoc
analysis suggested that the ethanol-treatment (E group) exhibited
significantly diminished spontaneous alternation compared
with saline-treatment (S group) as found in our previous
observations (Subbanna et al., 2013a). Pre-administration of
Q-VD-OPh before ethanol (E +Q-VD-OPh group) rescued these
deficits (F(3,33) = 23, p < 0.01; Figure 5E). Pre-administration
of Q-VD-OPh before saline treatment (S + Q-VD-OPh
group) failed to significantly affect the spontaneous alternation
performance (p > 0.05). Altogether, these results indicated that
inhibition of caspase-3 activity prevents the impact of ethanol
exposure at P7 on spatial memory defects in adult mice.
P7 Pre-administration of Q-VD-OPh before
Ethanol Treatment Rescues
Ethanol-Induced Social Recognition
Memory Loss in Adult Mice
Consistent with our previous observations (Subbanna and
Basavarajappa, 2014; Subbanna et al., 2015a), the social
investigation performance of P7 ethanol-treated adult mice
was significantly reduced compared with that of the saline-
treated mice. Two-way ANOVA analysis suggested that
pre-administration of Q-VD-OPh significantly rescued the
ethanol-induced (E + Q-VD-OPh; F(3,33) = 10, p < 0.01) SRM
deficits compared with those of the saline or S + Q-VD-OPh
treated mice (Figure 5F). Importantly, S + Q-VD-OPh alone had
no significant effect (p> 0.05) on SRM, and these mice exhibited
normal social interactions with juvenile mice when compared
with the saline-treated mice (p > 0.05). These results indicate
that caspase-3 inhibition before P7 ethanol exposure is effective
in rescuing SRM loss in adult mice.
Q-VD-OPh Pre-administration before
Ethanol Treatment Prevents the
Ethanol-Induced LTP Deficits
To understand whether pre-administration of Q-VD-OPh
rescues ethanol-induced LTP deficits, we examined LTP at
the Schaffer collateral pathway of hippocampal slices derived
from adult male mice treated with saline, ethanol, saline
+ Q-VD-OPh or ethanol + Q-VD-OPh at P7. First, we
measured the input/output (I/O) responses, in which fEPSP
slopes were recorded in response to single electrical stimuli of
increasing magnitude in adult hippocampal slices. Robust I/O
responses (Subbanna et al., 2013a; Subbanna and Basavarajappa,
2014) were observed in all treatment groups and were not
altered by ethanol or Q-VD-OPh treatment (p > 0.05;
data not shown). Prior to Theta-Burst Stimulation (TBS),
the baseline fEPSP was recorded at 60 s intervals with a
stimulation intensity equivalent to ∼35% of the maximum
evoked response (10 min). Application of the TBS induced
robust LTP in saline-treated animals and was stable over
120 min. However, TBS resulted in substantially weakened LTP
in slices derived from P7 ethanol-treated mice (p < 0.01).
Pre-administration of Q-VD-OPh prior to ethanol treatment
rescued the TBS-evoked LTP deficits found in P7 ethanol-
treated adult mice (p< 0.01) with a significant group interaction
(two-way ANOVA; F(1,36) = 36, p < 0.01; Bonferroni’s post
hoc analysis; n = 10 slices/5 mice/group; Figures 6A,B).
Pre-administration of Q-VD-OPh before saline treatment in
P7 mice failed to alter LTP responses (p > 0.05) in adult mouse
hippocampal slices (Figure 6C).
Treatment of P7 Mice with Q-VD-OPh
before Ethanol Exposure Prevents the
Ethanol-Induced Deficits in
Activity-Dependent Signaling Events and
Arc Expression
To examine the function of intracellular signaling events in
the long-lasting effects of ethanol even more in-depth, we
determined the levels of several signaling molecules (pCaMKIV,
pCREB, pMeCP2 and Arc) that are important for activity-
dependent development of synaptic circuits (Shieh and Ghosh,
1999; Cohen et al., 2011; Nagendran and Hardy, 2011) in
the HP. The schematic in Figure 6D shows the experimental
design for this study. Two-way ANOVA with Bonferroni’s
post hoc analysis suggested significant effects of ethanol (vs.
saline; pCaMKIV: F(3,33) = 25, p < 0.01; pCREB: F(3,33) = 22,
p < 0.01; pMeCP2: F(3,33) = 10, p < 0.01; Arc: F(3,33) = 42,
p < 0.01) and a significant interaction between ethanol
and Q-VD-OPh (pCaMKIV: F(3,33) = 18, p < 0.01; pCREB:
F(3,33) = 12, p < 0.01; pMeCP2: F(3,33) = 9, p < 0.01;
Arc: F(3,33) = 22, p < 0.01) in P90 mice. Q-VD-OPh
(data not shown) or saline alone had no significant effects
on pCaMKIV, pCREB, pMeCP2 and Arc protein levels
(p > 0.05) in adult naive mice. P7 Q-VD-OPh- (data not
shown) or saline-treated mice exhibited enhanced pCaMKIV
(Figure 6E1), pCREB (Figure 6E2), pMeCP2 (Figure 6E3) and
Arc (Figure 6E4) protein levels (p< 0.01) after Y-maze behavior
compared with saline-treated naive adult mice. However,
P7 ethanol-treated mice failed to enhance pCaMKIV, pCREB,
pMeCP2 and Arc protein levels (p < 0.01) after Y-maze
behavior when compared with P7 ethanol-treated naive adult
mice.
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FIGURE 4 | Pharmacological blockades of caspase-3 activation protects against ethanol-induced inhibition of CREB phosphorylation and epigenetic-mediated
activity regulated cytoskeleton-associated protein (Arc) expression in the mouse brain. P7 pups were injected with Q-VD-OPh (1 mg/kg) 30 min before first saline or
ethanol exposure and were either sacrificed after 8 h or were allowed to mature to adulthood and then sacrificed. (A) P7 and (B) adult hippocampal (HP) and
neocortical (NC) nuclear extracts from the four treatment groups (S + V, E + V, S + Q-VD-OPh, or E + Q-VD-OPh) were subjected to western blotting to analyze the
levels of pCREB, CREB and Arc (n = 10 pups/group). The representative blots are shown for the hippocampal and cortical nuclear extracts (∗p < 0.01 vs. S + V;
#p < 0.01 vs. E + V). β-actin was used as the loading control. (C) Adult hippocampal nuclear extracts from the four treatment groups (S + V, E + V, S + Q-VD-OPh,
or E + Q-VD-OPh) were subjected to RT-qPCR to analyze the Arc mRNA levels. Hprt mRNA was used as the internal control for normalization of Arc mRNA.
(D) Epigenetic analysis at the promoter region of the Arc gene. ChIP analysis of the Arc gene promoter in HP tissues from the four treatment groups (S + V, E + V, S +
Q-VD-OPh, or E + Q-VD-OPh) with anti-acetylated H3K14 or anti-H3K9me2 antibodies. Levels of Arc gene promoter chromatin enrichment in the IPs were
measured by RT-qPCR. Error bars, SEM (two-way ANOVA with Bonferroni’s post hoc test).
DISCUSSION
In this study, several lines of evidence demonstrate for the
first time that postnatal ethanol treatment impairs MeCP2 via
CB1R-dependent caspase-3-mediated protein degradation in
the P7 mouse brain, causing long-lasting signaling, Arc gene
expression, and synaptic and behavioral deficits in adult mice.
These results support the notion that the MeCP2 protein
expression pattern is correlated with neuronal development or
maturation and is impaired by postnatal ethanol treatment.
A CB1R antagonist rescued and genetic deletion of CB1R
prevented loss of MeCP2 protein, and they both are known
to prevent the caspase-3 activation (Subbanna et al., 2013a,b,
2015a; Subbanna and Basavarajappa, 2014) in P7 mice. Directly
inhibiting caspase-3 with an inhibitor (Q-VD-OPh) also rescued
the ethanol-induced loss of MeCP2 protein in P7 mice. In
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FIGURE 5 | Administration of a caspase-3 inhibitor before ethanol treatment in P7 mice rescues persistent spatial and social recognition memory (SRM) deficits in
adulthood. (A,B) The spatial working memory was determined using the Y-maze in adult mice treated with saline (S), ethanol (E), S + Q-VD-OPh, or E + Q-VD-OPh
at P7. The discrimination ratio [preference for the novel arm over the familiar other arm (Novel/Novel + Other)] for arms entries (A) and dwell time (time spent in each
arm) (B) of S, E, S + Q-VD-OPh and E + Q-VD-OPh -treated mice, 24 h after the first encounter with the partially opened maze. The dashed line denotes chance
performance (0.5). (C–E) The spontaneous alternation memory of adult mice treated with saline (S), ethanol (E), S + Q-VD-OPh, or E + Q-VD-OPh at P7 was
evaluated using the Y-maze. (C) The number of arm entries by mice in all the treatment groups. (D) The time spent in each arm by mice in all the treatment groups.
(E) The spontaneous alternation performance by mice in all the treatment groups. (F) The percent of social investigation is shown for P7 S, E, S + Q-VD-OPh and E
+ Q-VD-OPh -treated adult mice, 24 h after the first encounter with the same juvenile mice. (∗p < 0.01 vs. saline; $p < 0.05 vs. saline; #p < 0.05 vs. ethanol,
n = 8 mice/group). Error bars, SEM (two-way ANOVA with Bonferroni’s post hoc test).
humans and rodents, enhanced MeCP2 levels are present during
postnatal development (Balmer et al., 2003; Olson et al., 2014).
This developmental expression pattern suggests that MeCP2 can
regulate synaptic function (Zoghbi, 2003). MeCP2 is more
enriched in the brain than in most other tissues (Lasalle
et al., 2001; Shahbazian et al., 2002), is highly expressed in
neurons but less in glia (Ballas et al., 2009), and is localized
to cell nuclei (Akbarian et al., 2001; Lasalle et al., 2001;
Shahbazian et al., 2002). The loss of MeCP2 found in the current
study combined with the impaired DNMT1 and DNMT3A
expression and DNA methylation in ethanol-treated postnatal
mice (Nagre et al., 2015) may lead to long-lasting defects in
gene expression, and synaptic and behavioral outcomes in adult
animals. Hence, inhibition of caspase-3 activity before ethanol
treatment prevented ethanol-induced persistent impairments in
signaling, Arc gene expression, and synaptic and behavioral
outcomes in adult mice. The observation of synaptic deficits
is consistent with previous studies reporting that excitatory
synaptic transmission is impaired in cultured hippocampal
neurons derived from MeCP2 null mice (Nelson et al., 2006;
Chao et al., 2007), or vice versa in mice overexpressing MeCP2
(Chao et al., 2007; Na et al., 2012, 2013). Additionally, reduced
hippocampal slice LTP and learning and memory behavior is
found in MeCP2 null mice (Asaka et al., 2006; Moretti et al.,
2006; Guy et al., 2007; Na et al., 2012, 2013). Taken together,
our results suggest that MeCP2 plays an essential role in the
postnatal ethanol-induced defects in synaptic circuit maturation
in the developing brain.
Dynamic modification of DNA methylation and binding
partners of methylation machinery, such as MeCP2, occur in
a tissue, and time-specific manner and appear to be critically
important for early brain development (Matsuda and Yasutomi,
1992; Kakutani et al., 1996; Martin et al., 1999). Ethanol exposure
during embryonic development was shown to modulate DNA
methylation patterns (Garro et al., 1991; Haycock and Ramsay,
2009; Liu et al., 2009; Ouko et al., 2009; Downing et al.,
2011; Zhou et al., 2011), and is implicated in the etiology
of numerous developmental abnormalities (Ouko et al., 2009;
Kaminen-Ahola et al., 2010). Our recent study (Nagre et al.,
2015) suggested that ethanol-induced CB1R-mediated caspase-3
degrades DNMT1 and DNMT3A proteins, causing DNA
hypomethylation in P7 mice. Consistent with this observation, in
another of our studies (Subbanna et al., 2013b) ethanol-activated
caspase-3 in P7 mice cleaves explicitly dimethylated (lysine 9)
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FIGURE 6 | Administration of a caspase-3 inhibitor before P7 ethanol treatment prevents long-term potentiation (LTP) deficits in adult male mice. (A) A schematic
drawing shows the stimulating and recording electrode positions in the CA1 region of the HP. (B) The average field-excitatory-post-synaptic potential (fEPSP) slope
at various time points obtained from P7 saline (S), ethanol (E), S + Q-VD-OPh, or E + Q-VD-OPh-treated adult mice. For each slice, the fEPSP slopes were
normalized against the average slope over the 10-min recording before LTP stimulation. Arrows show the time of Theta-Burst Stimulation (TBS; four pulses at
100 Hz, with bursts repeated at 5 Hz, and each tetanus including three different 10-burst trains separated by 15 s). Inset: representative traces before and after TBS
are shown for all the treatment groups. Scale 1 mV; 10 ms. (C) Bar graph compares the average of the fEPSP slopes at several time points after TBS in P7 saline (S),
ethanol (E), S + Q-VD-OPh, or E + Q-VD-OPh-treated adult mice hippocampal slices. (∗p < 0.01 vs. saline, n = 5 mice/group; 10 slices/group). (D) Scheme
indicating the experimental design to evaluate the effects of pre-administration of Q-VD-OPh before saline/ethanol treatment in P7 mice on activity-dependent
signaling events in adulthood. The spatial working memory of adult mice treated with saline (S), ethanol (E), S + Q-VD-OPh, or E + Q-VD-OPh at P7 was evaluated
using a Y-maze. (E) HP tissues were collected immediately after a 24 h intertrial interval when the mice completed exploring all three arms (3 min, preference trial,
test trial). The signaling proteins (E1) pCaMKIV, (E2) pCREB, (E3) pMeCP2 and (E4) Arc were examined in nuclear or cytosolic extracts of the HP from saline (S),
ethanol (E), S + Q-VD-OPh, or E + Q-VD-OPh groups (n = 8 mice/group) via western blot analysis. Equal protein loading was confirmed after Ponceau S staining,
and β-actin was used as a protein loading control (∗p < 0.01 vs. S; #p < 0.01 vs. E; &p < 0.01 vs. S+V; $p < 0.01 vs S; @p < 0.01 vs E. Error bars, SEM (two-way
ANOVA with Bonferroni’s post hoc test).
histone proteins. In another study, direct inhibition of DNA
methylation by 5-azacytidine (5-AzaC) at P7 also caused Arc
deficits, resulting in neurodegeneration in neonatal mice and
long-lasting impaired Arc expression and behavioral defects in
adult mice (Subbanna et al., 2016). Together, these observations
suggest that postnatal ethanol-activated caspase-3 can impact
epigenetic control of gene expression through modulation of
MeCP2 and DNMTs for a short period during postnatal
development. Thus, this can lead to persistent neurological and
behavioral deficits in adult mice (Subbanna et al., 2013a, 2015a;
Subbanna and Basavarajappa, 2014), as observed in animal
models of FASD (Izumi et al., 2005; Wilson et al., 2011; Sadrian
et al., 2012; Subbanna et al., 2013a; Subbanna and Basavarajappa,
2014).
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FIGURE 7 | Schematic diagram showing the molecular mechanism by which
CB1R-mediated activation of caspase-3 degrades MeCP2, leading to
neurobehavioral abnormalities in postnatal ethanol-exposed mice. It was
revealed previously that P7 ethanol treatment activates CB1R and inhibits
pCREB and Arc expression, leading to neurodegeneration in neonatal mice
and persistent neurobehavioral abnormalities in adult mice (Subbanna et al.,
2015a). Here, we show that inhibition of CB1R (Subbanna et al., 2013a, 2014)
or caspase-3 prevents loss of MeCP2 and rescues pCREB/Arc defects in
neonatal mice. Inhibition of caspase-3 in P7 mice also protected against the
synaptic plasticity, Arc expression, activity-dependent signaling and behavioral
defects in adult mice exposed to ethanol at P7. These observations suggest
that CB1R (Subbanna et al., 2013a, 2014)/caspase-3-mediated MeCP2 loss
in early development causes neurobehavioral abnormalities in postnatal
ethanol-exposed adult mice (↓, ethanol effects; ⊥, drug effects).
We found a contrasting effect of ethanol treatment of P7 mice
on the expression levels of Mecp2 mRNA and protein. Although
a similar discrepancy betweenMeCP2 protein andMecp2mRNA
levels was shown in mouse brain tissues (Shahbazian et al.,
2002; Dura et al., 2008), postnatal ethanol exposure may enhance
transcription of the MECP2 gene, but robust activation of
caspase-3 resulted in proteolytic degradation of MeCP2 protein.
In our previous studies (Subbanna et al., 2013b), we showed that
dimethylated H3K9 acts as a substrate for activated caspase-3.
Similarly, a CB1R antagonist, which is known to inhibit
ethanol-induced caspase-3-mediated (Subbanna et al., 2013a)
degradation of DNMT1 and DNMT3A proteins and reduce
DNA methylation (Nagre et al., 2015) in P7 mice, prevented
MeCP2 protein degradation. Furthermore, genetic ablation
of CB1R, which provides protection from ethanol-activated
caspase-3 (Subbanna et al., 2013a)-mediated degradation of
DNMT1 and DNMT3A proteins, and DNA hypomethylation
(Nagre et al., 2015) in P7 mice and long-lasting neurobehavioral
defects in adulthood (Subbanna et al., 2013a), also revived
MeCP2 protein levels that had been lowered by ethanol.
These findings may indicate that the observed reduction in
MeCP2 protein levels for a short period during a critical
window of synaptic maturation (Marchal and Mulle, 2004;
Lanore et al., 2010) can have a long-lasting effect on
epigenetic regulation and synaptic circuit formation, leading
to neurobehavioral defects, as observed in mice (Subbanna
et al., 2013a, 2015a; Subbanna and Basavarajappa, 2014)
and human FASD (Mattson et al., 2011; Lebel et al.,
2012; Norman et al., 2013). This hypothesis is supported
by the observation that SR141716A and the use of CB1R
KO mice protected against P7 ethanol-mediated caspase-3
activation and persistent behavioral problems in adult mice
(Subbanna et al., 2013a,b, 2015a; Subbanna and Basavarajappa,
2014).
The levels of cellular proteins that regulate biological
processes are controlled by missionaries that are involved in
transcription, translation, post-translational and degradation.
Under steady-state conditions, most cellular proteins undergo
continuous synthesis, modification and degradation processes
to adjust to both internal and environmental stimuli. The
presence of many caspase-3 substrates was shown in the nucleus
(Fischer et al., 2003), and has been suggested to play a crucial
role in the nuclear morphological changes that occur in most
cells undergoing apoptosis (Kamada et al., 2005). Although
the connection between neurodegeneration and MeCP2 protein
stability in the developing brain is lacking, our findings suggest
that regulation of MeCP2 turnover might be of importance.
Consistent with this suggestion, low-dose ethanol treatment
of P7 mice, which induces significantly lower amounts of
caspase-3 activation in P7 mice, enhances MeCP2 levels without
any proteolytic degradation (Subbanna et al., 2014). Prenatal
ethanol exposure during pregnancy also enhanced Mecp2 gene
expression in rats (Bekdash et al., 2013; Perkins et al., 2013).
It was shown that chronic ethanol exposure led to lower
5-mc levels and up regulated MeCP2 levels, while ethanol
withdrawal reduced expression in embryonic differentiating
brain cells (Liyanage et al., 2015). Additionally, prenatal exposure
to ethanol during early pregnancy significantly decreased
MeCP2 levels in both the prefrontal cortex and striatum of
offspring (Kim et al., 2013). Furthermore, fetal alcohol exposure
also caused a significant increase in MeCP2 in hypothalamus
proopiomelanocortin (POMC) cells as well as at the Pomc gene
promoter (Gangisetty et al., 2014). Therefore, our current study
demonstrates that MeCP2 proteins may serve as substrates for
widely activated caspase-3 in ethanol-treated P7 mouse brains.
Thus, the caspase-3 inhibitor (Q-VD-OPh) prevents the loss
of MeCP2 protein in ethanol-exposed P7 mice. However, our
study does not exclude other possible proteolytic mechanisms
involved in the loss of MeCP2 in ethanol-treated P7 mice.
Similar degradation of MeCP2 was found in ethanol-treated
murine embryonic fibroblasts (MEFs; Mukhopadhyay et al.,
2013). Additionally, pretreatment of MEFs with the proteosomal
inhibitor MG-132 before ethanol exposure completely prevented
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the degradation of MeCP2 protein (Mukhopadhyay et al., 2013).
Previous findings have shown that several RTT mutations
are characterized by a decrease in MeCP2 stability (Ballestar
et al., 2000; Yusufzai and Wolffe, 2000; Free et al., 2001).
MeCP2 was shown to be ubiquitinated by an E3 ubiquitin ligase
(RNF4), and this leads to the removal of MeCP2 from gene
promoters, leading to activation of transcription (Wang, 2014).
The biological function of RNF4 is broad, and it has been shown
to target many proteins for degradation (Hu et al., 2010). Future
studies of the mechanisms (e.g., ubiquitination and protein
degradation) related to MeCP2 protein stability and turnover
that lead to an imbalance in MeCP2 protein levels would provide
more insight into neurodevelopmental disorders resulting from
environmental insults, including FASD. Thus, it is possible that,
during early neurodevelopment, ethanol-induced impairments
of MeCP2 and DNA methylation (Nagre et al., 2015) may affect
the binding of transcription factors to gene promoter regions,
leading to suppression of the expression of genes (e.g., Arc) that
encode survival factor(s) (Kokubo et al., 2009), whichmay impact
neuronal development and neurobehavioral abnormalities, such
as deficits in synaptic plasticity, and learning and memory in
adult animals (Noel et al., 2011; Wilson et al., 2011; Sadrian et al.,
2012; Subbanna et al., 2013a). Indeed, developmental alcohol,
including postnatal ethanol exposure, impairs LTP and the
performance of several behavioral tasks related to learning and
memory (Abel et al., 1983; Bonthius and West, 1991; Bellinger
et al., 1999, 2002; Berman and Hannigan, 2000; Alati et al.,
2006; Brown et al., 2007; Brady et al., 2013; Subbanna et al.,
2013a, 2015a; Subbanna and Basavarajappa, 2014; Basavarajappa,
2015).
Our previous findings indicated the involvement of the
ERK1/2-pCREB-Arc pathway, which operates on neuronal
survival downstream of the CB1Rs in the developing brain
(Subbanna et al., 2013a,b). Ethanol treatment during postnatal
development was shown to impair this pathway (Subbanna
et al., 2013a, 2015a). The current study replicated these previous
findings and suggests that deficits in CREB activation and Arc
expression last into adulthood and can be rescued by either
pre-administration of CB1R antagonist or a caspase-3 inhibitor
before P7 ethanol treatment. In addition, by using a ChIP
assay, we demonstrated a marked increase in H3K9me2 and
a reduction in H3K14ace at the Arc gene promoter. Loss
of MeCP2 could silence Arc gene transcription by recruiting
HDAC (Nan et al., 1997, 1998) or G9a (Fuks et al., 2003;
Coward et al., 2017), both of which have been shown to
remove acetyl groups from histones or methylate histones
respectively, resulting in gene suppression. Additionally, reduced
pCREB levels can impair CBP (HAT) recruitment to gene
promoters (Lonze and Ginty, 2002; Lubin et al., 2008), leading
to reduced acetylation of histone proteins. Together, these
events can alter H3K9me2 and H3K14ace (Basavarajappa and
Subbanna, 2016) to repress Arc expression. These findings
provide epigenetic mechanisms for the P7 ethanol-induced
long-lasting Arc expression deficits, which are a significant
part of synaptic function and cognitive behavior (Donai
et al., 2003; Chowdhury et al., 2006; Bramham et al., 2008;
Kawashima et al., 2009; Korb and Finkbeiner, 2011; Yamada
et al., 2011; Dyrvig et al., 2012). It should be emphasized
here that ethanol-induced inhibition of the CB1R-regulated
ERK1/2-pCREB-Arc signaling pathway might disrupt the
proper development of synaptic circuits, leading to lasting
synaptic, learning and memory defects (Abel et al., 1983;
Bonthius and West, 1991; Bellinger et al., 1999, 2002;
Berman and Hannigan, 2000; Alati et al., 2006; Brown
et al., 2007; Brady et al., 2013; Subbanna et al., 2013a,
2015a; Subbanna and Basavarajappa, 2014; Basavarajappa, 2015).
Similarly, CB1RKO mice do not portray P7 ethanol-induced
neurodegeneration or a loss of DNMTs (Hansen et al., 2008;
Subbanna et al., 2013a; Basavarajappa, 2015; Nagre et al., 2015)
and MeCP2 during the neonatal period or deficits in LTP,
learning and memory during adulthood (Subbanna et al., 2013a;
Basavarajappa, 2015; Nagre et al., 2015). These observations
together suggest that signaling events and epigenetic changes
that occur during the neurodegeneration process in the
developing brain are crucial for understanding the etiology
of FASD.
Our data suggests that P7 ethanol-treated adult mice exposed
to Y-maze behavior exhibit deficits in activity-dependent
signaling events, such as activation of CaMKIV and CREB, and
formation of Arc. We also found reduced pCaMKIV, pCREB,
pMeCP2 and Arc expression in P7 ethanol-treated adult mice
not exposed to Y-maze behavior (basal deficits). Although
Y-maze behavior failed to enhance pMeCP2 in P7 saline-
treated adult mice, it was successful in improving pMeCP2 in
P7 ethanol-treated adult mice. A previous study using cultured
cortical neurons suggested that loss of pMeCP2 leads to
impaired dendritic and synaptic development (Cohen et al.,
2011). Using slices containing the visual cortex from P16 to
P17 mice, it was shown that activity-dependent activation
of MeCP2 through phosphorylation is necessary for the
proper maturation of cortical synaptic circuits (Cohen et al.,
2011). It should be noted that activity-dependent changes
in the neurons contribute to the adequate maturation of
neural circuits during development (Hong et al., 2005).
Furthermore, activity-dependent changes in signaling events and
gene transcription are required in the persistent refinement
of neural circuits (Arancio et al., 1995; Taha and Stryker,
2002; Lu, 2003; Tabuchi, 2008; Kawashima et al., 2009).
Interestingly, neural activity during development has been
shown to regulate the activity of many genes (West and
Greenberg, 2011), including Arc gene expression, through
several signaling events (Plath et al., 2006; Rial Verde
et al., 2006; Chotiner et al., 2010). Whether or not such
regulation is under the control of MeCP2 phosphorylation
needs to be investigated in future studies. Nevertheless, the
observed activity-dependent impairments that are important
for stabilizing the activity-dependent refinement of the neural
circuits (Wong and Ghosh, 2002; Van Aelst and Cline,
2004; Fox and Wong, 2005) could also lead to persistent
learning and memory deficits, as observed in animal models
of FASD (Abel et al., 1983; Bonthius and West, 1991;
Bellinger et al., 1999, 2002; Berman and Hannigan, 2000;
Alati et al., 2006; Brown et al., 2007; Brady et al., 2013;
Subbanna et al., 2013a, 2015a; Subbanna and Basavarajappa,
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2014; Basavarajappa, 2015). The previous (Subbanna et al.,
2013a, 2015a) and current findings together strongly suggest
that characterization of CB1R downstream targets that regulate
pCREB-mediated epigenetic events, gene expression, and the
effects of developmental (postnatal) ethanol exposure may
ultimately aid in the development of therapeutic drugs to
reduce the symptoms of developmental ethanol neurobehavioral
teratogenicity.
In conclusion, the present study presents several lines of
evidence indicating that postnatal ethanol treatment reduces
the levels of MeCP2 protein in a CB1R-mediated caspase-
3-dependent manner, which has a crucial role in gene
expression regulation. The experimental evidence in the
current study provides novel mechanistic insights into the
developmental effects of ethanol and indicate that ethanol may
disrupt MeCP2 proteins, leading to persistent deficits in Arc
gene expression and synaptic impairments (Figure 7). These
events occur within the developing brain and are responsible
for persistent neurobehavioral impairments similar to those
observed in FASD.
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